Active ingredientDifamilastCat. No. P-D108-001CAS 937782-05-3Family · Pharmaceutical analytical standards
Difamilast
A non-steroidal phosphodiesterase 4 (PDE4) inhibitor ointment for mild to moderate atopic dermatitis, approved in Japan in 2021 for adults and children aged 2 and over, and in the United States in 2026. This family brings together the active ingredient.
Did you know?The ending -milast is shared by several PDE4 inhibitors, such as apremilast, roflumilast and cilomilast: a kind of family surname.
Go to the active ingredient →Active ingredientDifamilastCat. No. P-D108-001CAS 937782-05-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.